ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Orphazyme A/S Investors With Losses Exceeding $100K to Secure Counsel Before Important September 7 Deadline in Securities Class Action – ORPH

Author's Avatar
Aug 03, 2021

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Orphazyme A/S (NASDAQ: ORPH): (1) pursuant and/or traceable to Orphazyme’s September 29, 2020 initial public offering (the “IPO” or “Offering”); and/or (2) between September 29, 2020 and June 18, 2021, inclusive, (the “Class Period”) of the important September 7, 2021 lead plaintiff deadline in the securities class action.